CordenPharma is pleased to announce that their CordenPharma Chenôve (France)
manufacturing facility recently completed an FDA Inspection and received a successful response with no 483s reported. The last FDA Inspection took place in 2014.
, Managing Director of CordenPharma Chenôve
comments, “We are pleased with the outcome of the FDA Inspection in August 2016, as it reflects our willingness to comply with the highest level of cGMP regulatory compliance while continuously improving our standards for our customers and their projects going forward.”
Read the Full Press Release Here.